KORU Medical Systems (KRMD) Net Income towards Common Stockholders (2010 - 2026)
KORU Medical Systems' (KRMD) quarterly Net Income towards Common Stockholders came in at -$807078.0 in Q1 2026, up 30.8% year-on-year from -$617049.1 in Q1 2025, and up 20.43% on a QoQ basis from -$1.0 million in Q4 2025.
KORU Medical Systems (KRMD) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has 12 years of Net Income towards Common Stockholders data on file, last reported at -$807078.0 in Q1 2026.
- On a quarterly basis, Net Income towards Common Stockholders rose 30.8% year-over-year to -$807078.0 in Q1 2026; TTM through Mar 2026 was -$2.8 million, a 46.99% increase from a year earlier, with the FY2025 full-year figure at -$3.2 million, up 47.77% from the prior year.
- Net Income towards Common Stockholders for Q1 2026 stood at -$807078.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Net Income towards Common Stockholders for KRMD reached as high as -$206867.0 in Q2 2025 and fell as low as -$6.2 million in Q4 2022.
- Historically, Net Income towards Common Stockholders has averaged -$2.0 million across 5 years, with a median of -$1.6 million in 2024.
- Across the five-year window, Net Income towards Common Stockholders sank 159.78% in 2022 and surged 79.08% in 2025, its largest moves.
- Year by year, Net Income towards Common Stockholders stood at -$6.2 million in 2022, then rose by 10.94% to -$5.6 million in 2023, then jumped by 71.93% to -$1.6 million in 2024, then jumped by 34.91% to -$1.0 million in 2025, then increased by 20.43% to -$807078.0 in 2026.
- Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$807078.0 in Q1 2026, -$1.0 million in Q4 2025, and -$777966.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 126.84 Bn | 121.63 Bn | 1.96 Bn | 823.20 Mn |
| 2 | Becton Dickinson | 44.96 Bn | 44.15 Bn | 2.15 Bn | -274.00 Mn |
| 3 | Alcon | 33.16 Bn | 31.50 Bn | 1.53 Bn | 22.13 Bn |
| 4 | Medline | 32.82 Bn | 30.58 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 23.41 Bn | 22.97 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Solventum | 14.09 Bn | 13.53 Bn | 1.10 Bn | 13.00 Mn |
| 8 | Cooper Companies | 13.85 Bn | 13.71 Bn | 735.40 Mn | -77.90 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | KORU Medical Systems | 185.46 Mn | 176.66 Mn | 7.23 Mn | -807,078.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -807,078.00 |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -777,966.00 |
| Jun 30, 2025 | -206,867.00 |
| Mar 31, 2025 | -1.17 Mn |
| Dec 31, 2024 | -1.56 Mn |
| Sep 30, 2024 | -1.58 Mn |
| Jun 30, 2024 | -988,715.00 |
| Mar 31, 2024 | -1.94 Mn |
| Dec 31, 2023 | -5.55 Mn |
| Sep 30, 2023 | -1.37 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | -2.41 Mn |
| Dec 31, 2022 | -6.23 Mn |
| Sep 30, 2022 | -1.23 Mn |
| Jun 30, 2022 | -2.92 Mn |
| Mar 31, 2022 | -2.54 Mn |
| Dec 31, 2021 | -4.21 Mn |
| Sep 30, 2021 | -1.09 Mn |
| Jun 30, 2021 | -1.12 Mn |